Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease.
about
Hereditary spastic paraplegia proteins REEP1, spastin, and atlastin-1 coordinate microtubule interactions with the tubular ER networkMechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylationThioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signalingProteomic characterization of acyclovir-induced nephrotoxicity in a mouse model.Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.Anamorsin, a novel caspase-3 substrate in neurodegeneration.Baicalin inhibits colistin sulfate-induced apoptosis of PC12 cells.Proteomic study of calpeptin-induced differentiation on calpain-interacting proteins of C2C12 myoblast.PPARalpha expression protects male mice from high fat-induced nonalcoholic fatty liver.Cysteine-based redox switches in enzymesPeroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.Mechanisms of Nrf2 protection in astrocytes as identified by quantitative proteomics and siRNA screeningOverview of peroxiredoxins in oxidant defense and redox regulation.Thiol redox homeostasis in neurodegenerative diseaseFormation of dopamine adducts derived from brain polyunsaturated fatty acids: mechanism for Parkinson diseaseIncreased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver.Peroxiredoxin 1 suppresses apoptosis via regulation of the apoptosis signal-regulating kinase 1 signaling pathway in human oral leukoplakiaTransgenic overexpression of peroxiredoxin-2 attenuates ischemic neuronal injury via suppression of a redox-sensitive pro-death signaling pathwayThiol-redox signaling, dopaminergic cell death, and Parkinson's diseaseAmperometric measurements of catecholamine release from single vesicles in MN9D cellsSulfiredoxin Translocation into Mitochondria Plays a Crucial Role in Reducing Hyperoxidized Peroxiredoxin III.The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells.Typical 2-Cys peroxiredoxins--structures, mechanisms and functions.The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells.Gel-based protease proteomics for identifying the novel calpain substrates in dopaminergic neuronal cell.2-cys peroxiredoxins: emerging hubs determining redox dependency of Mammalian signaling networks.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.The antioxidant enzyme peroxiredoxin and its protective role in neurological disorders.Tumor Necrosis Factor-Associated Protein 1 (TRAP1) is Released from the Mitochondria Following 6-hydroxydopamine Treatment.Levodopa activates apoptosis signaling kinase 1 (ASK1) and promotes apoptosis in a neuronal model: implications for the treatment of Parkinson's disease.Metabolic Dysfunction in Parkinson's Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism.Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell death.Neuroprotective effects of PrxI over-expression in an in vitro human Alzheimer's disease model.Nigericin-induced impairment of autophagic flux in neuronal cells is inhibited by overexpression of Bak.Microarray expression profiling in 6-hydroxydopamine-induced dopaminergic neuronal cell death.Molecular cloning and characterization of peroxiredoxin 4 involved in protection against oxidative stress in the silkworm Bombyx mori.Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cordLipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine.Peroxiredoxin distribution in the mouse brain with emphasis on neuronal populations affected in neurodegenerative disorders.Dominant role of peroxiredoxin/JNK axis in stemness regulation during neurogenesis from embryonic stem cells.
P2860
Q24301595-9407550C-C258-4455-BF48-26633870F799Q26830954-ED0A38EB-4EFD-4959-AF23-BA95F5D0EB48Q28389739-BDEBCDB9-827B-4E00-AB9E-36AE06B55742Q33940210-E4595B1B-5AD5-4F20-B7CE-9D65B491FDBEQ34026030-FA0098B0-5A6A-4A97-9E5C-26E1BB22F4F5Q34070411-CE988FD5-37BF-4D76-8C81-1CA867AAAAF5Q34095133-1CF0429A-7435-483E-8F08-CFA68F078B4CQ34136912-F71E9D30-752A-4701-B4D1-76C7316F0580Q34667494-3B06691C-B77D-444E-A504-69663F53422BQ34722134-09FDBEF8-4359-42D6-97C2-DD9C66B34185Q34806527-4BCF4F19-0476-47E3-AF8E-DA8D4B80D750Q34906371-0F0F152F-5E16-4D33-954C-25CB0335540DQ35165680-AEBDE1A3-EB9F-4EAE-99C8-9969185BDCB4Q35614227-1C638575-66C7-4A4F-A0AC-F1D023C86376Q35676862-F1B5D0E1-3C4C-4D21-91DD-1DA44914783FQ35909784-69C4C587-179E-4FF5-A25B-8D0418F77E0AQ35944275-18A47382-14FE-465A-A2E9-754EDA3AA550Q36070865-01992A04-155F-4CD3-9C70-4C13C2D43702Q36326535-871FC233-45F8-40F6-B25B-847DA955F1C0Q37120719-E6E968EA-9AF2-429B-8D6E-8FA16622FCC6Q37136773-403C71F0-ADA1-496F-AF63-D3E537A8A93FQ37158230-0BD94052-5316-4E32-B023-B8A429AB35AAQ37354876-1771C09D-B81C-469A-AEF8-51FE259136D6Q37399751-FD31BF7E-6AA1-4D4C-B348-FCE629E8BDB7Q37405074-D61C3479-2EE2-4F9C-95BB-A3283D06FCE9Q37598512-29ABD602-7CC7-40FD-9C3B-1EF8453099BFQ37685124-B6E0DD74-4DFD-4EDF-9D5A-41535AF3E84AQ37981135-61E0B99C-D4BE-49BF-91A2-407FC02A9C18Q38725685-5A751CC3-8000-43A5-A392-8F19484D15C6Q38753946-8BA942F2-6BC8-4455-A433-520FB5DE0D95Q39199926-DD048E30-8806-4015-9C83-A3BFB0A6A368Q39231661-BAEF7875-3894-4C6C-B37C-A05DC77F54C1Q39260922-2CEE17A4-644D-4A03-AB13-92F6D2517069Q39366109-C5A57190-D4F5-43E0-A4FC-43632F5FE3A9Q39476786-2409B039-6A1A-4C42-B0DC-1C12F38B0D72Q42011736-263B8992-C1EE-442C-84CC-813D9A021DC4Q42040656-083ACD42-DC68-49DA-AB72-88403A428692Q42444390-FE29BD0F-E7C7-43E0-A83B-622EE087E4B5Q42489979-493392AA-41DC-47B9-B4AF-E92CA7188288Q46908010-513FE4F8-B5AA-484E-854A-751DF9943D52
P2860
Oxidative modification of peroxiredoxin is associated with drug-induced apoptotic signaling in experimental models of Parkinson disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Oxidative modification of pero ...... l models of Parkinson disease.
@en
type
label
Oxidative modification of pero ...... l models of Parkinson disease.
@en
prefLabel
Oxidative modification of pero ...... l models of Parkinson disease.
@en
P2093
P2860
P356
P1476
Oxidative modification of pero ...... l models of Parkinson disease.
@en
P2093
Bokyung Park
Byung K Jin
Dong-Ik Shin
Jee-Yeon Hwang
Seong H Park
Young J Oh
Young Mook Lee
P2860
P304
P356
10.1074/JBC.M800426200
P407
P577
2008-02-04T00:00:00Z